This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.
- pp. 37-41.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Scientific Validity
Adolescent / Secondary School Age,
Attention Deficit Hyperactivity Disorder,
Pervasive Developmental Disorder (Not Otherwise Specified),
Primary / Elementary School Age,
Selective Noradrenaline Re-Uptake Inhibitor,
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Publications Database |